↓ Skip to main content

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Overview of attention for article published in Alzheimer's Research & Therapy, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 1,161)
  • High Attention Score compared to outputs of the same age (99th percentile)

Citations

dimensions_citation
1231 Dimensions

Readers on

mendeley
1427 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
Published in
Alzheimer's Research & Therapy, January 2014
DOI 10.1186/alzrt269
Pubmed ID
Authors

Jeffrey L Cummings, Travis Morstorf, Kate Zhong

Abstract

Alzheimer's disease (AD) is increasing in frequency as the global population ages. Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist. We have an urgent need to find new therapies for AD.

Twitter Demographics

The data shown below were collected from the profiles of 69 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1,427 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 <1%
Germany 3 <1%
Spain 3 <1%
France 2 <1%
India 2 <1%
Belgium 2 <1%
Japan 2 <1%
United Kingdom 2 <1%
Australia 1 <1%
Other 8 <1%
Unknown 1398 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 310 22%
Researcher 212 15%
Student > Bachelor 204 14%
Student > Master 189 13%
Student > Doctoral Student 73 5%
Other 216 15%
Unknown 223 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 203 14%
Neuroscience 195 14%
Biochemistry, Genetics and Molecular Biology 177 12%
Medicine and Dentistry 135 9%
Pharmacology, Toxicology and Pharmaceutical Science 97 7%
Other 322 23%
Unknown 298 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 1862. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2022.
All research outputs
#4,160
of 22,167,602 outputs
Outputs from Alzheimer's Research & Therapy
#1
of 1,161 outputs
Outputs of similar age
#21
of 203,765 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#1
of 1 outputs
Altmetric has tracked 22,167,602 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,161 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,765 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them